- Call or text: +1 (808) 261-4476
- Mon-Fri (8:30am - 4:30pm) Lunch Break 12:30pm-1:30pm
- info@hawaiineuroscience.com
Edit Content
Conditions | Indications | Study Name | Treatment | NIH Website | Who Qualifies |
---|---|---|---|---|---|
Alzheimer’s Memory | Mild Moderate AD | LIFT (Neuro Synaptic) | Fosgonimeton | NCT04488419 | MMSE 14-24 |
Alzheimer’s Memory | Mild Moderate AD | (Axonal Transport) | Buntanetap | NCT05686044 | MMSE 14-24 |
Alzheimer’s Memory | MCI Mild AD | ENVISION (Amyloid0 | Aducanumab | NCT05310071 | MMSE > 22 |
Alzheimer’s Memory | MCI Mild AD | CELIA (Tau ASO) | BIIB080 | NCT05399888 | MMSE > 22 |
Alzheimer’s Memory | MCI Mild AD | LIGHTWAVE (NMDA) | SAGE-718 | NCT05619692 | MoCA 15-25/MMSE > 22 |
Parkinson’s | Early PD | LUMA (LRRK2) | BIIB1222 | NCT05348785 | PD within 2 years |
Parkinson’s | Early PD | (Axonal Transport) | Buntanetap | NCT05357989 | H&Y 1-3 On state |
Parkinson’s | Tremor | (Calcium) | Suvecaltamide | NCT05122650 | Moderate to Severe PD Tremor |
Essential Tremor | EVEREST (Calcium) | Suvecaltamide | NCT05122650 | Moderate to Severe Tremor | |
Epilepsy | Focal | REALIZE | CVL-865 | NCT04244175 | > 4 seizures/month |
Epilepsy | Focal | X-TOLE2 | XEN1101 | NCT05614063 | Seizures > 2 years |
Epilepsy | PGTC | X-TOLE3 | XEN1101 | NCT05667142 | 3 PGTC in 8 weeks |
Abortive | Focal or Generalized | STARS | EP0162 or 0165 | NCT05077904 | Seizures |
Spasticity | DIRETION | Dysport | NCT04936542 | Upper limb Spasticity > 3 mths | |
Headache | Migraine | LAHV/LAHW | Lasmiditan | NCT04396236 | Migraine > 6 mths |
Huntington’s Chorea | DIMENSION | SAGE-718 | NCT04396236 | CAG Mutation > 40U | |
Multiple System Atrophy CYPRESS | Ampreloxetine | NCT05696717 | Neurogenic Orthostatic > SBP or > 10 DBP |
Principal Investigator, Clinical Research Center Hawaii Pacific Neuroscience Clinical Professor, Dept. of Medicine (Neurology), Graduate Faculty, Clinical & Translational Research University of Hawai`i John Burns School of Medicine